Kiora Pharmaceuticals KPRX
NASDAQ KPRX
$2.56 -0.02 (-0.78%)
At close: Oct 2, 2026 · 4:00 PM EDT

Kiora Pharmaceuticals (KPRX) Other Accumulated Expenses (2020 - 2022)

Updated

Kiora Pharmaceuticals' Other Accumulated Expenses was $15,630 in Q3 2022.

Analysis

Kiora Pharmaceuticals (KPRX) Other Accumulated Expenses (2020 - 2022) Analysis & Trends

At the end of FY2021, Other Accumulated Expenses at Kiora Pharmaceuticals came in at $28,961, down 77.3% from FY2020.

  • In earlier years, Other Accumulated Expenses was $127,730 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Kiora Pharmaceuticals 15.81 Mn 15.81 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 15,630.00
Dec 31, 2021 28,961.00
Dec 31, 2020 127,730.00
API Access

Kiora Pharmaceuticals Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=KPRX&period=max&api_key=YOUR_API_KEY